Cargando…
Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
The fate of Mycobacterium tuberculosis infection is governed by immune signaling pathways that can either eliminate the pathogen or result in tuberculosis (TB). Anti-TB therapy (ATT) is extensive and is efficacious only against active, drug-sensitive strains of M. tuberculosis. Due to severe side ef...
Autores principales: | Kumari, Anjna, Pahuja, Isha, Negi, Kriti, Ghoshal, Antara, Mukopadhyay, Suparba, Agarwal, Meetu, Mathew, Babu, Maras, Jaswinder Singh, Chaturvedi, Shivam, Bhaskar, Ashima, Dwivedi, Ved Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100980/ https://www.ncbi.nlm.nih.gov/pubmed/36916966 http://dx.doi.org/10.1128/spectrum.00583-23 |
Ejemplares similares
-
Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023) -
SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
por: Bhaskar, Ashima, et al.
Publicado: (2023) -
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023) -
Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2
por: Negi, Kriti, et al.
Publicado: (2023) -
Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022)